LncRNA GAS5 promotes abdominal aortic aneurysm formation through regulating the miR-185-5p/ADCY7 axis Wang, Yulong; Zhai, Shuiting; Xing, Jianwu; More Wang, Yulong; Zhai, Shuiting; Xing, Jianwu; He, Yingkun; Li, Tianxiao Less Anti-Cancer Drugs. 33(3):225-234, March 2022. Abstract Abstract Favorites PDF Get Content & Permissions Buy SDC
Lidocaine hampers colorectal cancer process via circITFG2/miR-1204/SOCS2 axis Wang, Huashe; Zhang, Xuexia; Li, Yi; More Wang, Huashe; Zhang, Xuexia; Li, Yi; Li, Yanan; Pang, Ting Less Anti-Cancer Drugs. 33(3):235-244, March 2022. Abstract Abstract Favorites PDF Get Content & Permissions Buy SDC
Circ_0005033 is an oncogene in laryngeal squamous cell carcinoma and regulates cell progression and Cisplatin sensitivity via miR-107/IGF1R axis Gong, Lei; Chen, Juan; Jiang, Xijiao Gong, Lei; Chen, Juan; Jiang, Xijiao Less Anti-Cancer Drugs. 33(3):245-256, March 2022. Abstract Abstract Favorites PDF Get Content & Permissions Buy SDC
Circular RNA circPDSS1 promotes osteosarcoma progression by sponging miR-502-3p and miR-4436a Tang, Shaolong; Tang, Xinhai; Jin, Zhengping; More Tang, Shaolong; Tang, Xinhai; Jin, Zhengping; Liu, Chao; Huang, Qinghua; Wang, Laijie; Diaty, Diarra Mohamed; Ye, Zhaoming Less Anti-Cancer Drugs. 33(3):257-267, March 2022. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Open
Heat shock protein 47 promotes cell migration and invasion through AKT signal in non-small cell lung cancer Wu, Wei; Hu, Zhenzhen; Xiong, Linkai; More Wu, Wei; Hu, Zhenzhen; Xiong, Linkai; Zou, Juntao Less Anti-Cancer Drugs. 33(3):268-277, March 2022. Abstract Abstract Favorites PDF Get Content & Permissions Buy
Growth arrest-specific 5 lncRNA as a valuable biomarker of chemoresistance in osteosarcoma Polvani, Simone; Martignano, Filippo; Scoccianti, Guido; More Polvani, Simone; Martignano, Filippo; Scoccianti, Guido; Pasqui, Adriano; Palomba, Anna Rita; Conticello, Silvo; Galli, Andrea; Palchetti, Ilaria; Caporalini, Chiara; Antonuzzo, Lorenzo; Campanacci, Domenico Andrea; Pillozzi, Serena Less Anti-Cancer Drugs. 33(3):278-285, March 2022. Abstract Abstract Favorites PDF Get Content & Permissions Buy
CircCDK1 knockdown reduces CDK1 expression by targeting miR-489-3p to suppress the development of breast cancer and strengthen the sensitivity of Tamoxifen Liu, Di; Zhou, Zhangjian; Guo, Yize; More Liu, Di; Zhou, Zhangjian; Guo, Yize; Du, Qin; Li, Liang Less Anti-Cancer Drugs. 33(3):286-299, March 2022. Abstract Abstract Favorites PDF Get Content & Permissions Buy
Rovalpituzumab tesirine resistance: analysis of a corresponding small cell lung cancer and circulating tumor cell line pair Rath, Barbara; Plangger, Adelina; Krenbek, Dagmar; More Rath, Barbara; Plangger, Adelina; Krenbek, Dagmar; Hochmair, Maximilian; Stickler, Sandra; Tretter, Verena; Hamilton, Gerhard Less Anti-Cancer Drugs. 33(3):300-307, March 2022. Abstract Abstract Favorites PDF Get Content & Permissions Buy
miR-26b-5p suppresses chemoresistance in breast cancer by targeting serglycin Du, Qiwei; Yuan, Zuguo; Huang, Xiaoling; More Du, Qiwei; Yuan, Zuguo; Huang, Xiaoling; Huang, Yuqing; Zhang, Jie; Li, Rongguo Less Anti-Cancer Drugs. 33(3):308-319, March 2022. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Open
Response to erlotinib and bevacizumab combination therapy after acquired resistance to osimertinib in patients with non-small cell lung cancer Satoh, Hiroaki; Kagohashi, Katsunori Satoh, Hiroaki; Kagohashi, Katsunori Less Anti-Cancer Drugs. 33(3):320-322, March 2022. Abstract Abstract Favorites PDF Get Content & Permissions Buy
